Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood

Journal of Experimental Medicine - Tập 197 Số 6 - Trang 711-723 - 2003
Lynda Bennett1,2, A. Karolina Palucka1, Edsel Arce1,2, V. Ashley Cantrell1,2, Jozef Borvak1, Jacques Banchereau1, Virginia Pascual1,2
11Baylor Institute for Immunology Research, Dallas, TX 75204
22The University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390

Tóm tắt

Systemic lupus erythematosus (SLE) is a prototype systemic autoimmune disease characterized by flares of high morbidity. Using oligonucleotide microarrays, we now show that active SLE can be distinguished by a remarkably homogeneous gene expression pattern with overexpression of granulopoiesis-related and interferon (IFN)-induced genes. Using the most stringent statistical analysis (Bonferroni correction), 15 genes were found highly up-regulated in SLE patients, 14 of which are targets of IFN and one, defensin DEFA-3, a major product of immature granulocytes. A more liberal correction (Benjamini and Hochberg correction) yielded 18 additional genes, 12 of which are IFN-regulated and 4 granulocyte-specific. Indeed immature neutrophils were identified in a large fraction of SLE patients white blood cells. High dose glucocorticoids, a standard treatment of disease flares, shuts down the interferon signature, further supporting the role of this cytokine in SLE. The expression of 10 genes correlated with disease activity according to the SLEDAI. The most striking correlation (P < 0.001, r = 0.55) was found with the formyl peptide receptor-like 1 protein that mediates chemotactic activities of defensins. Therefore, while the IFN signature confirms the central role of this cytokine in SLE, microarray analysis of blood cells reveals that immature granulocytes may be involved in SLE pathogenesis.

Từ khóa


Tài liệu tham khảo

2001, Immunity., 15, 397, 10.1016/S1074-7613(01)00201-1

2001, Nat. Rev. Immunol., 1, 147, 10.1038/35100573

2001, N. Engl. J. Med., 345, 340, 10.1056/NEJM200108023450506

2000, J. Immunol., 164, 4697, 10.4049/jimmunol.164.9.4697

2002, J. Immunol., 168, 2530, 10.4049/jimmunol.168.5.2530

2001, Nat. Immunol., 2, 764, 10.1038/ni0901-764

2001, J. Immunol., 167, 2361, 10.4049/jimmunol.167.4.2361

1986, J. Immunol., 137, 2528, 10.4049/jimmunol.137.8.2528

1994, J. Exp. Med., 179, 1317, 10.1084/jem.179.4.1317

1997, Arthritis Rheum., 40, 2217, 10.1002/art.1780401217

2000, Annu. Rev. Immunol., 18, 767, 10.1146/annurev.immunol.18.1.767

2000, J. Exp. Med., 191, 411, 10.1084/jem.191.3.411

2001, Science., 294, 1540, 10.1126/science.1064890

1982, Science., 216, 429, 10.1126/science.6176024

2001, Annu. Rev. Immunol., 19, 163, 10.1146/annurev.immunol.19.1.163

2001, Immunity., 15, 375, 10.1016/S1074-7613(01)00194-7

2000, Annu. Rev. Immunol., 18, 829, 10.1146/annurev.immunol.18.1.829

2002, Lancet., 359, 1301, 10.1016/S0140-6736(02)08270-3

1978, Histochemistry., 58, 241, 10.1007/BF00495380

1995, J. Exp. Med., 182, 1597, 10.1084/jem.182.5.1597

2002, Blood., 99, 4030, 10.1182/blood-2001-12-0271

1999, J. Exp. Med., 189, 1343, 10.1084/jem.189.8.1343

2002, J Biol Chem, 277, 28504, 10.1074/jbc.M204851200

1998, Immunity., 9, 325, 10.1016/S1074-7613(00)80615-9

1999, J. Leukoc. Biol., 66, 989, 10.1002/jlb.66.6.989

1985, Inflammation., 9, 163, 10.1007/BF00917588

2001, J. Leukoc. Biol., 69, 691, 10.1189/jlb.69.5.691

2002, Cell., 109(Suppl), S57

2001, J. Exp. Med., 194, F59, 10.1084/jem.194.12.f59

2001, Immunity., 15, 435, 10.1016/S1074-7613(01)00196-0

2000, Immunol. Today., 21, 424, 10.1016/S0167-5699(00)01675-3

1983, Clin. Exp. Rheumatol., 1, 133

2001, Am. J. Pathol., 159, 237, 10.1016/S0002-9440(10)61689-6

2001, Lupus., 10, 484, 10.1191/096120301678416042

1986, Arthritis Rheum., 29, 1334, 10.1002/art.1780291105

1985, Am. J. Hematol., 20, 235, 10.1002/ajh.2830200305

1997, Clin. Exp. Immunol., 107, 359

2000, Cytokines Cell. Mol. Ther., 6, 149, 10.1080/mccm.6.3.149.154

2001, Immunity., 14, 693, 10.1016/S1074-7613(01)00150-9

1996, Clin. Nephrol., 45, 211

1996, Am. J. Pathol., 149, 81

1999, Ann. Rheum. Dis., 58, 309, 10.1136/ard.58.5.309